IsoTis Appoints Jean-Pierre Boucher, Former President Stryker Europe, to Board
Lausanne, Switzerland, and Irvine, CA - IsoTis OrthoBiologics is pleased to announce the appointment of Jean-Pierre Boucher to the Board of Directors at its recent annual general shareholders meeting.
Mr. Boucher brings close to 40 years of experience in the healthcare industry. He was at Stryker Corporation, the world's largest orthopaedic company, for 18 years, 14 of which he served as President Stryker Europe, with responsibility for all Stryker activities in Europe, including distribution, manufacturing, and R&D, overseeing 1100 employees. During his tenure, European sales exceeded $ 400 million annually. Mr. Boucher retired from Stryker Corporation in April of this year.
IsoTis' CEO Jacques Essinger commented: "We are delighted to have attracted a person of Mr. Boucher's experience and outstanding reputation to our Board. His in-depth knowledge of the orthopedics market and industry will provide us with invaluable guidance in achieving our growth objectives."
.
Most read news
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

3-D printed guide helps regrow complex nerves after injury
Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company
'Dynamic' Phlexglobal Impresses Judges To Secure Investors In People Status
Viral life cycle of malignant catarrhal fever explained
Rare genetic disease successfully reversed using stem cell transplantation - Scripps Research scientists correct gene defect in mice that causes lethal symptoms in children
